NeuroSense Therapeutics Ltd. — 424B3 Filings
16 424B3 filings on record
This page lists all 424B3 filings submitted to the SEC by NeuroSense Therapeutics Ltd. (NRSNW), sorted by most recent first. Each row links to the full filing on EdgarLookup. NeuroSense Therapeutics Ltd. has filed 16 424B3 documents with the SEC since 2021. To view all SEC filings by NeuroSense Therapeutics Ltd., see the full filings list.
All
20-F
3
424B3
424B4
424B5
6-K
6-K/A
8-A12B
AW
CERT
CORRESP
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
FWP
POS AM
POS EX
S-8
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B3 | PROSPECTUS | 0001213900-25-115498 | Nov 26, 2025 | — |
| 424B3 | PROSPECTUS | 0001213900-25-004599 | Jan 17, 2025 | — |
| 424B3 | PROSPECTUS | 0001213900-24-108444 | Dec 12, 2024 | — |
| 424B3 | PROSPECTUS | 0001213900-24-101629 | Nov 22, 2024 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-056337 | Jun 27, 2024 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-056332 | Jun 27, 2024 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-053413 | Jun 17, 2024 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-053411 | Jun 17, 2024 | — |
| 424B3 | PROSPECTUS | 0001213900-24-045958 | May 22, 2024 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-23-098942 | Dec 27, 2023 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-23-095739 | Dec 14, 2023 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-23-093080 | Dec 5, 2023 | — |
| 424B3 | PROSPECTUS | 0001213900-23-093076 | Dec 5, 2023 | — |
| 424B3 | PROSPECTUS | 0001213900-23-075009 | Sep 7, 2023 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-22-042187 | Jul 28, 2022 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-22-019938 | Apr 15, 2022 | — |